HK1012285A1 - Paroxetine tablets and process to prepare them - Google Patents

Paroxetine tablets and process to prepare them

Info

Publication number
HK1012285A1
HK1012285A1 HK98113624A HK98113624A HK1012285A1 HK 1012285 A1 HK1012285 A1 HK 1012285A1 HK 98113624 A HK98113624 A HK 98113624A HK 98113624 A HK98113624 A HK 98113624A HK 1012285 A1 HK1012285 A1 HK 1012285A1
Authority
HK
Hong Kong
Prior art keywords
prepare
paroxetine tablets
paroxetine
tablets
Prior art date
Application number
HK98113624A
Other languages
English (en)
Inventor
Ram Dutta Pathak
David George Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1012285(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1012285A1 publication Critical patent/HK1012285A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK98113624A 1993-12-15 1998-12-16 Paroxetine tablets and process to prepare them HK1012285A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (1)

Publication Number Publication Date
HK1012285A1 true HK1012285A1 (en) 1999-07-30

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113624A HK1012285A1 (en) 1993-12-15 1998-12-16 Paroxetine tablets and process to prepare them

Country Status (36)

Country Link
US (1) US6113944A (xx)
EP (1) EP0734260B2 (xx)
JP (1) JP3037757B2 (xx)
KR (1) KR100367796B1 (xx)
CN (1) CN1071116C (xx)
AP (1) AP540A (xx)
AT (1) ATE180973T1 (xx)
AU (1) AU697982B2 (xx)
BG (1) BG62755B1 (xx)
BR (1) BR9408219A (xx)
CA (4) CA2178637C (xx)
CZ (1) CZ287891B6 (xx)
DE (1) DE69419033T2 (xx)
DK (1) DK0734260T4 (xx)
DZ (1) DZ1835A1 (xx)
ES (1) ES2132610T5 (xx)
FI (1) FI962445A (xx)
GB (1) GB9325644D0 (xx)
GR (1) GR3031047T3 (xx)
HK (1) HK1012285A1 (xx)
HU (1) HUT75880A (xx)
IL (1) IL111978A (xx)
MA (1) MA23395A1 (xx)
MY (1) MY112123A (xx)
NO (1) NO307366B1 (xx)
NZ (1) NZ277790A (xx)
OA (1) OA10297A (xx)
PL (1) PL314980A1 (xx)
RO (1) RO115413B1 (xx)
RU (1) RU2146141C1 (xx)
SA (1) SA94150373B1 (xx)
SI (1) SI0734260T2 (xx)
SK (1) SK282620B6 (xx)
UA (1) UA42745C2 (xx)
WO (1) WO1995016448A1 (xx)
ZA (1) ZA949900B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5874447A (en) 1997-06-10 1999-02-23 Synthon B. V. 4-Phenylpiperidine compounds for treating depression
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
AU5078700A (en) * 1999-06-22 2001-01-09 Smithkline Beecham Plc Novel composition
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
UA79930C2 (en) 2001-07-31 2007-08-10 Lundbeck & Co As H Crystalline composition containing escitalopram
HUP0401895A2 (hu) * 2001-10-22 2004-12-28 Synthon B.V. Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
IL162458A0 (en) * 2001-12-28 2005-11-20 Teva Pharma A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
CN1997374A (zh) * 2004-06-23 2007-07-11 默克公司 雌激素受体调节剂
WO2006018318A1 (en) * 2004-08-18 2006-02-23 Synthon B.V. Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
CA2629514A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (xx) * 1974-03-04 1975-09-11
ZA813205B (en) † 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
CA2096853A1 (en) * 1990-11-24 1992-05-25 Anthony Michael Johnson Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
SI0734260T2 (sl) 2008-12-31
IL111978A0 (en) 1995-03-15
BG62755B1 (bg) 2000-07-31
HUT75880A (en) 1997-05-28
US6113944A (en) 2000-09-05
JPH09506602A (ja) 1997-06-30
NZ277790A (en) 1998-02-26
NO962547L (no) 1996-06-14
BR9408219A (pt) 1997-08-26
CN1137236A (zh) 1996-12-04
CA2274389C (en) 2004-09-14
CA2178637A1 (en) 1995-06-22
EP0734260A1 (en) 1996-10-02
EP0734260B2 (en) 2008-07-09
CZ176396A3 (en) 1996-09-11
WO1995016448A1 (en) 1995-06-22
KR100367796B1 (ko) 2003-07-22
ES2132610T5 (es) 2008-12-16
PL314980A1 (en) 1996-09-30
DZ1835A1 (fr) 2002-02-17
DK0734260T3 (da) 1999-11-15
ZA949900B (en) 1995-10-10
NO307366B1 (no) 2000-03-27
NO962547D0 (no) 1996-06-14
EP0734260B1 (en) 1999-06-09
MY112123A (en) 2001-04-30
SA94150373B1 (ar) 2006-05-27
MA23395A1 (fr) 1995-07-01
SK282620B6 (sk) 2002-10-08
CA2178637C (en) 1997-12-23
AU697982B2 (en) 1998-10-22
CA2214575C (en) 1999-12-07
HU9601665D0 (en) 1996-08-28
CA2274387A1 (en) 1995-06-22
ATE180973T1 (de) 1999-06-15
GB9325644D0 (en) 1994-02-16
ES2132610T3 (es) 1999-08-16
AP540A (en) 1996-09-20
UA42745C2 (uk) 2001-11-15
DE69419033T2 (de) 1999-11-25
IL111978A (en) 2000-07-16
AP9400704A0 (en) 1995-01-31
SA94150373A (ar) 2005-12-03
CA2274389A1 (en) 1995-06-22
SI0734260T1 (en) 1999-08-31
DE69419033D1 (de) 1999-07-15
RO115413B1 (ro) 2000-02-28
CN1071116C (zh) 2001-09-19
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
CA2214575A1 (en) 1995-06-22
GR3031047T3 (en) 1999-12-31
RU2146141C1 (ru) 2000-03-10
BG100648A (bg) 1997-02-28
DK0734260T4 (da) 2008-09-29
AU1314595A (en) 1995-07-03
FI962445A0 (fi) 1996-06-12
JP3037757B2 (ja) 2000-05-08
CZ287891B6 (cs) 2001-03-14
FI962445A (fi) 1996-06-12

Similar Documents

Publication Publication Date Title
HK1012285A1 (en) Paroxetine tablets and process to prepare them
NZ235242A (en) 1-cycloalkyl piperidines and pharmaceutical compositions
EP0434313A3 (en) Enhanced direct bond process and structure
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
GB2216386B (en) Canning process and composition
HU216713B (hu) Ciklusos acetálok és eljárás az előállításukra
GB9420539D0 (en) Process and composition
HUT71606A (en) Amino-ascorbic acid derivatives, halogen-ascorbic acid derivatives and process to prepare them
HUP9602470A3 (en) Tablets containing captopril and process for producing them
GB2282966B (en) A pharmaceutical composition having anti-decrepit action and a process for preparation thereof
GB2275922B (en) Bifilm process and plant
IL91973A0 (en) Tin organofluorides and process for their preparation
HUT59154A (en) Process for producing 6-methyl-19-norsteroids and pharmaceutical compositions comprising same
GB9004313D0 (en) Conversion composition and process
HUT71517A (en) Process to prepare (2-benzyloxy-6-nitrophenyl)-acetonitril
HU9303259D0 (en) New pharmaceutical composition and process for producing them
HU9403074D0 (en) Transdermal pharmaceutical compositions and process for producing them
HU9500156D0 (en) Pharmaceutical composition and process
HUT66861A (en) Lignane analogues and process to prepare them
GB9302509D0 (en) Pharmaceutical process
GB9326222D0 (en) Composition and process
HUT69389A (en) Amino-ciklohexane-derivatives and process for their production
GB8922867D0 (en) Pharmaceutical method and compositions
GB8922866D0 (en) Pharmaceutical method and compositions
GB8904434D0 (en) Conversion composition and process

Legal Events

Date Code Title Description
PF Patent in force
AM Amended specification (according sect 146 of patent law)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101214